Priya JayachandranPharmdMse

Priya JayachandranPharmdMse

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5395032
-
person_outline Priya JayachandranPharmdMse's MOST POPULAR ARTICLES
1-) Pharmacokinetics and safety of 3 months of weekly rifapentine and isoniazid for tuberculosis prevention in pregnant womenJS Mathad, R Savic, P Britto, P Jayachandran, L Wiesner, G Montepiedra, ...Clinical Infectious Diseases 74 (9), 1604-1613, 2022222022
2-) Subcutaneous administration of monoclonal antibodies: pharmacology, delivery, immunogenicity, and learnings from applications to clinical developmentJD Davis, M Bravo Padros, DJ Conrado, S Ganguly, X Guan, HE Hassan, ...Clinical Pharmacology & Therapeutics 115 (3), 422-439, 2024192024
3-) Characterizing HIV-preventive, plasma tenofovir concentrations—a pooled participant-level data analysis from human immunodeficiency virus preexposure prophylaxis clinical trialsM Garcia-Cremades, K Vučićević, CW Hendrix, P Jayachandran, ...Clinical Infectious Diseases 75 (11), 1873-1882, 2022172022
4-) Evaluating within‐subject variability for narrow therapeutic index drugsP Jayachandran, H Okochi, LA Frassetto, W Park, L Fang, L Zhao, ...Clinical Pharmacology & Therapeutics 105 (2), 411-416, 2019132019
5-) Results from a phase 1 study of sodium selenite in combination with palliative radiation therapy in patients with metastatic cancerSJ Knox, P Jayachandran, CA Keeling, KJ Stevens, N Sandhu, ...Translational oncology 12 (11), 1525-1531, 2019102019